226 related articles for article (PubMed ID: 16249446)
21. Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.
Faradji RN; Froud T; Messinger S; Monroy K; Pileggi A; Mineo D; Tharavanij T; Mendez AJ; Ricordi C; Alejandro R
Cell Transplant; 2009; 18(10):1247-59. PubMed ID: 20003758
[TBL] [Abstract][Full Text] [Related]
22. Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes.
Rickels MR; Naji A; Teff KL
J Clin Endocrinol Metab; 2006 Jun; 91(6):2138-44. PubMed ID: 16569741
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.
Ryan EA; Shandro T; Green K; Paty BW; Senior PA; Bigam D; Shapiro AM; Vantyghem MC
Diabetes; 2004 Apr; 53(4):955-62. PubMed ID: 15047610
[TBL] [Abstract][Full Text] [Related]
24. Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes.
Israelian Z; Gosmanov NR; Szoke E; Schorr M; Bokhari S; Cryer PE; Gerich JE; Meyer C
Diabetes Care; 2005 Nov; 28(11):2691-6. PubMed ID: 16249541
[TBL] [Abstract][Full Text] [Related]
25. Preserved insulin secretion and insulin independence in recipients of islet autografts.
Pyzdrowski KL; Kendall DM; Halter JB; Nakhleh RE; Sutherland DE; Robertson RP
N Engl J Med; 1992 Jul; 327(4):220-6. PubMed ID: 1614463
[TBL] [Abstract][Full Text] [Related]
26. Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver.
Meier JJ; Hong-McAtee I; Galasso R; Veldhuis JD; Moran A; Hering BJ; Butler PC
Diabetes; 2006 Aug; 55(8):2324-32. PubMed ID: 16873697
[TBL] [Abstract][Full Text] [Related]
27. Native pancreatic alpha-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantation.
Dufrane D; Maillart JF; Aouassar N; Goebbels RM; Guiot Y; Gianello P
Xenotransplantation; 2009; 16(3):152-63. PubMed ID: 19566655
[TBL] [Abstract][Full Text] [Related]
28. Quantitative measurement of islet glucagon response to hypoglycemia by confocal fluorescence imaging in diabetic rats: effects of phlorizin treatment.
Rastogi KS; Cooper RL; Shi ZQ; Vranic M
Endocrine; 1997 Dec; 7(3):367-75. PubMed ID: 9657075
[TBL] [Abstract][Full Text] [Related]
29. [Function of pancreas transplants in increased metabolic stress].
Teuscher AU; Seaquist ER; Barrou Z; Kendall DM; Robertson RP
Swiss Surg; 1995; (4):188-92. PubMed ID: 9156819
[TBL] [Abstract][Full Text] [Related]
30. Indications for clinical islet transplantation today and in the forseeable future--the diabetologist's point of view.
Federlin K; Pozza G
J Mol Med (Berl); 1999 Jan; 77(1):148-52. PubMed ID: 9930951
[TBL] [Abstract][Full Text] [Related]
31. Reversal of Hypoglycemia Unawareness with a Single-donor, Marginal Dose Allogeneic Islet Transplantation in Korea: A Case Report.
Yang HK; Ham DS; Park HS; Rhee M; You YH; Kim MJ; Kim JW; Lee SH; Hong TH; Choi BG; Cho JH; Yoon KH
J Korean Med Sci; 2015 Jul; 30(7):991-4. PubMed ID: 26130966
[TBL] [Abstract][Full Text] [Related]
32. Hepatic insulin resistance after pancreas transplantation in type I diabetes.
Rooney DP; Robertson RP
Diabetes; 1996 Feb; 45(2):134-8. PubMed ID: 8549855
[TBL] [Abstract][Full Text] [Related]
33. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes.
Ghofaili KA; Fung M; Ao Z; Meloche M; Shapiro RJ; Warnock GL; Elahi D; Meneilly GS; Thompson DM
Transplantation; 2007 Jan; 83(1):24-8. PubMed ID: 17220786
[TBL] [Abstract][Full Text] [Related]
34. Association between the secretory unit of islet transplant objects index and satisfaction with insulin therapy among insulin-dependent islet recipients.
Takita M; Matsumoto S; Shimoda M; Chujo D; Itoh T; Iwahashi S; SoRelle JA; Onaca N; Naziruddin B; Levy MF
Transplant Proc; 2011 Nov; 43(9):3250-5. PubMed ID: 22099769
[TBL] [Abstract][Full Text] [Related]
35. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes.
Hering BJ; Kandaswamy R; Ansite JD; Eckman PM; Nakano M; Sawada T; Matsumoto I; Ihm SH; Zhang HJ; Parkey J; Hunter DW; Sutherland DE
JAMA; 2005 Feb; 293(7):830-5. PubMed ID: 15713772
[TBL] [Abstract][Full Text] [Related]
36. Five-year follow-up after clinical islet transplantation.
Ryan EA; Paty BW; Senior PA; Bigam D; Alfadhli E; Kneteman NM; Lakey JR; Shapiro AM
Diabetes; 2005 Jul; 54(7):2060-9. PubMed ID: 15983207
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
[TBL] [Abstract][Full Text] [Related]
38. Regulation of glucose homeostasis in humans with denervated livers.
Perseghin G; Regalia E; Battezzati A; Vergani S; Pulvirenti A; Terruzzi I; Baratti D; Bozzetti F; Mazzaferro V; Luzi L
J Clin Invest; 1997 Aug; 100(4):931-41. PubMed ID: 9259593
[TBL] [Abstract][Full Text] [Related]
39. Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures.
Rickels MR; Kong SM; Fuller C; Dalton-Bakes C; Ferguson JF; Reilly MP; Teff KL; Naji A
Am J Physiol Endocrinol Metab; 2014 May; 306(10):E1217-24. PubMed ID: 24691031
[TBL] [Abstract][Full Text] [Related]
40. Hormonal and metabolic counterregulation during and after high-dose insulin-induced hypoglycemia in diabetes mellitus type 2.
Bischof MG; Ludwig C; Hofer A; Kletter K; Krebs M; Stingl H; Nowotny P; Waldhäusl W; Roden M
Horm Metab Res; 2000 Oct; 32(10):417-23. PubMed ID: 11069207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
